Annual Report 2020

Elma - Solid results in a challenging year

Elma - Solid results in a challenging year

  • Order income of CHF 153.3 million increased by 0.7% adjusted for currency effects  (previous year: CHF 159.0 million)
  • Net sales of CHF 147.0 million 1.5% higher adjusted for currency effects (previous year: CHF 151.2 million)
  • EBIT of CHF 6.6 million (previous year: CHF 6.4 million) and net profit of CHF 5.6 million (previous year: CHF 5.1 million) improved due to significantly lower sales and other operating expenses
  • All three regions with a positive profit contribution
  • Operating cash flow increased by nearly 25% to CHF 10.3 million
  • Net debts reduced by CHF 7.1 million to CHF 16.9 million (previous year: CHF 24.0 million)
  • Equity ratio improved to 46.4% (December 31, 2019: CHF 42.6%)
  • A high level of innovation with significant product developments for the healthcare sector and five Technology Innovation Awards received

The year 2020 was impacted by the global Covid-19 pandemic which posed considerable challenges for companies. In this economically and entrepreneurially demanding environment, the Elma Group succeeded in slightly increasing order income as well as net sales adjusted for currency effects, improving profitability, and closing the financial year with a slightly higher net profit than last year.


Company Profile

The company profile provides general information about the organization, latest latest ad-hoc media releases, key figures and the Elma share.

Company profile


Annual Reports and Interim Reports from previous years for download

Annual Reports and Interim Reports

Investor Relations

Edwin Wild, CFO                                              Telephone +41 44 933 42 45

Send an email

Shareholder's register

Jasmine Loetscher                                      Telephone +41 44 933 42 91

Send an email